Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595717 | SCV000703529 | uncertain significance | not provided | 2016-12-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085436 | SCV001030187 | likely benign | Biotin-responsive basal ganglia disease | 2023-12-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002532420 | SCV003550556 | uncertain significance | Inborn genetic diseases | 2021-12-21 | criteria provided, single submitter | clinical testing | The c.1173-4A>T intronic alteration consists of a A to T substitution 4 nucleotides before coding exon 4 in the SLC19A3 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |